BioLineRx (BLRX) Institutional Ownership $4.53 -0.04 (-0.88%) Closing price 04:00 PM EasternExtended Trading$4.49 -0.04 (-0.88%) As of 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioLineRx (NASDAQ:BLRX)CurrentInstitutional OwnershipPercentage1.56%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$30.68MNumber ofInstitutional Sellers(last 12 months)0 Get BLRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioLineRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BLRX Institutional Buying and Selling by Quarter BioLineRx Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Highbridge Capital Management LLC1,010,012$215K0.0%N/A50.501% 11/1/2024Atria Investments Inc133,974$72K0.0%+27.9%0.168% 8/22/2024PVG Asset Management Corp123,580$70K0.3%N/A0.155% 8/15/2024CVI Holdings LLC815,683$462K0.4%N/A1.020% 3/12/2024PVG Asset Management Corp61,840$97K0.5%N/A0.085% 2/8/2024NorthRock Partners LLC17,125$27K0.0%N/A0.024% 12/1/2023B. Riley Wealth Advisors Inc.21,300$39K0.0%+88.5%0.029% 11/21/2023Allen Mooney & Barnes Investment Advisors LLC25,000$46K0.0%N/A0.035% 11/13/2023Rathbones Group PLC39,820$72K0.0%N/A0.065% 11/8/2023Values First Advisors Inc.48,348$88K0.1%N/A0.079% Get the Latest News and Ratings for BLRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioLineRx and its competitors with MarketBeat's FREE daily newsletter. 10/11/2023Geneos Wealth Management Inc.40,500$74K0.0%+72.3%0.066% 7/31/2023PVG Asset Management Corp61,840$99K0.4%-52.0%0.101% 5/16/2023Altium Capital Management LP2,279,657$2.02M1.1%-26.5%3.705% 11/14/2022Armistice Capital LLC2,797,048$2.59M0.0%N/A4.546% 11/14/2022Altium Capital Management LP4,149,262$3.84M1.4%N/A6.744% 11/8/2022Apollon Wealth Management LLC48,790$45K0.0%N/A0.079% 11/7/2022Virtu Financial LLC46,168$43K0.0%+195.6%0.075% 10/13/2022PVG Asset Management Corp47,860$44K0.2%N/A0.100% 7/22/2022Geneos Wealth Management Inc.41,450$53K0.0%+25.8%0.087% 5/13/2022Parkman Healthcare Partners LLC270,665$463K0.1%-36.9%0.568% 2/9/2022Geneos Wealth Management Inc.28,950$59K0.0%+63.1%0.061% 2/4/2022Envestnet Asset Management Inc.122,224$249K0.0%+184.7%0.256% 2/2/2022PVG Asset Management Corp160,360$327K1.2%+109.6%0.336% 1/28/2022ARK Investment Management LLC1,059,722$2.16M0.0%-1.3%2.223% 11/16/2021Schonfeld Strategic Advisors LLC12,100$33K0.0%N/A0.025% 11/16/2021Intellectus Partners LLC28,500$78K0.0%-29.6%0.060% 11/12/2021Parkman Healthcare Partners LLC411,060$1.13M0.3%-44.0%0.869% 11/10/2021PVG Asset Management Corp76,510$210K0.6%N/A0.162% 10/26/2021Game Plan Financial Advisors LLC25,000$69K0.0%-13.8%0.053% 9/17/2021Virtu Financial LLC16,578$47K0.0%N/A0.035% 8/13/2021Renaissance Technologies LLC77,808$219K0.0%-84.6%0.165% 8/11/2021Susquehanna Fundamental Investments LLC19,026$53K0.0%-74.5%0.040% 8/9/2021Cutter & CO Brokerage Inc.18,667$52K0.0%-34.9%0.039% 5/18/2021Morgan Stanley398,412$1.11M0.0%-45.6%0.875% 5/18/2021First Heartland Consultants Inc.10,000$28K0.0%N/A0.023% 5/18/2021Silverarc Capital Management LLC200,000$558K0.3%N/A0.465% 5/17/2021Schonfeld Strategic Advisors LLC76,500$213K0.0%+115.5%0.178% 5/17/2021Intellectus Partners LLC40,500$113K0.0%N/A0.094% 5/17/2021Goldman Sachs Group Inc.16,621$46K0.0%N/A0.039% 5/13/2021Renaissance Technologies LLC505,121$1.41M0.0%+89.2%1.174% Here's the last trade you should make before heading out for the weekend tomorrow. (Ad)Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Give me the details(Data available from 1/1/2016 forward) BLRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BLRX shares? During the previous two years, 10 institutional investors and hedge funds held shares of BioLineRx. The most heavily invested institutionals were CVI Holdings LLC ($462K), Highbridge Capital Management LLC ($215K), Values First Advisors Inc. ($88K), Geneos Wealth Management Inc. ($74K), Atria Investments Inc ($72K), Rathbones Group PLC ($72K), and PVG Asset Management Corp ($70K).Learn more on BioLineRx's institutional investors. What percentage of BioLineRx's stock is owned by institutional investors? 1.56% of BioLineRx's stock is owned by institutional investors. Learn more on BLRX's institutional investor holdings. Which institutional investors have been buying BioLineRx's stock? Of the 10 institutional investors that purchased BioLineRx's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($1.01M), CVI Holdings LLC ($815.68K), PVG Asset Management Corp ($185.42K), Values First Advisors Inc. ($48.35K), Rathbones Group PLC ($39.82K), Atria Investments Inc ($29.19K), and Allen Mooney & Barnes Investment Advisors LLC ($25K). How much institutional buying is happening at BioLineRx? Institutional investors have bought a total of 1,978,468 shares in the last 24 months. This purchase volume represents approximately $30.68M in transactions. Related Companies IMUX Institutional Ownership STRO Institutional Ownership QNTM Institutional Ownership SKYE Institutional Ownership MCRB Institutional Ownership IKNA Institutional Ownership MNOV Institutional Ownership ADAP Institutional Ownership ANRO Institutional Ownership CLSD Institutional Ownership This page (NASDAQ:BLRX) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLineRx Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLineRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.